Neurogene raises ~$134.8M in public offering of common stock and pre-funded warrants

Neurogene Inc.

Issued 3.5M shares at $30.00 and pre-funded warrants for 666,666 shares at $29.999999.
Underwriters exercised option for additional 624,999 shares; total net proceeds ~$134.8M.
Offering expected to close July 2, 2026; proceeds plus existing cash fund operations into Q1 2029.
Pre-funded warrants exercisable immediately, subject to 4.99%/9.99% beneficial ownership limitation.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.